Avondale Partners Downgrades TrueBlue (TBI) to Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Tech stocks bolster Wall Street as Nvidia quells AI growth concerns
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil rises by over $1 as White House says no US-Iran talks happening
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Revolution Medicines prices RASONQUE at $39,800 per month
- First Financial to acquire Hickory Point Bank in $111.3M deal
TrueBlue (TBI) Misses Q3 EPS by 5c, Q4 Guidance Falls Short
October 19, 2016 4:16 PM EDTTrueBlue (NYSE: TBI) reported Q3 EPS of $0.70, $0.05 worse than the analyst estimate of $0.75. Revenue for the quarter came in at $697.1 million versus the consensus estimate of $715.69 million.
GUIDANCE:
TrueBlue sees Q4 2016 EPS of $0.54-$0.59, versus the consensus of $0.69. TrueBlue sees Q4... More
